Ketamine for Monitored Anesthesia Care During Transcatheter Aortic Valve Replacement.

Purpose: To study the feasibility and outcomes of ketamine as an anesthetic adjunct during monitored anesthesia care (MAC) in transcatheter aortic valve replacement (TAVR).

Design: This was a retrospective study.

Methods: Data from 155 consecutive TAVR patients at a tertiary care high-volume TAVR medical center were reviewed and analyzed.

Closure of an iatrogenic ventricular septal defect using a hybrid approach and echocardiographic guidance.

Treatment of postsurgical iatrogenic ventricular septal defects (VSDs) remains a challenge. Surgical closure is associated with significant morbidity and mortality. A peripheral accessed percutaneous approach is faced with difficulties of gaining adequate access and complex positioning in a beating heart.